Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
The talk will outline the new concept of applying a 4 pillar approach in the treatment of diabetic and non-diabetic patients with kidney disease, which just became available recently. With the publication of the FLOW study on may 24 last month, the 4 foundational therapies available consist of RASi, SGLT2i, nsMRA and GLP1-RA. Despite these overwhelming advances in halting or retarding CKD progression, implementation barriers of these treatments exist. Many patients driving on the path to kidney replacement therapy will not receive these treatments. The barriers will be discussed.
Christoph Wanner is a senior professor of medicine in the Department of Clinical Studies and Epidemiology, University Hospital of Würzburg and a visiting professor of renal medicine at the Nuffield Department of Population Health, Clinical Trial Service Unit, University of Oxford.
